ASCO GU 2023: Treatment-free survival for advanced kidney cancer patients on nivolumab and salvage nivolumab/ipilimumab

By |2023-03-06T14:59:34+00:006 Mar 2023|Drug treatments|

In this study presented at the American Society of Clinical [...]